1/49
Comprehensive vocabulary flashcards reviewing the pathophysiology, clinical presentations, diagnostic assessments, and evidence-based interventions for neonatal complications based on nursing lecture notes.
Neonatal Resuscitation Program (NRP)
A standardized resuscitation protocol for neonates aged 28 days or less that focuses primarily on establishing respiratory support: Step 1 = Warm/Dry/Stimulate; Step 2 = Open and clear the airway; Step 3 = Support respiration (give oxygen and CPAP if breathing effort is present but labored; give positive pressure ventilation breaths if effort is poor); Step 4 = Chest compressions (initiated only after adequate ventilation is established if heart rate remains <60bpm); Step 5 = Emergency umbilical line placement with epinephrine and IV fluids.
Blended Oxygen Therapy
The precise combination of room air (21% oxygen) and pure oxygen (100% oxygen) titrated to achieve target oxygen saturations of 88–95% in preterm neonates and 92–98% in term neonates.
Negative Pressure Ventilation
Normal physiologic neonatal breathing generated when respiratory muscles contract to suck in air, producing negative pressure (a vacuum) within the thoracic cavity.
Positive Pressure Ventilation (PPV)
Artificial mechanical ventilation achieved by generating positive pressure to push the lungs open and deliver an inspiratory breath.
Continuous Positive Airway Pressure (CPAP)
A non-invasive pressurized breathing circuit delivered via nasal prongs or a face mask that provides continuous distending pressure to hold the lungs open and maintain functional residual capacity in infants with increased work of breathing without delivering forced breaths.
Non-Invasive Positive Pressure Ventilation (NIPPV)
A non-invasive ventilatory mode that combines continuous positive airway pressure (CPAP) with machine-delivered, positive pressure forced breaths administered via nasal prongs or a face mask.
Transient Tachypnea of the Newborn (TTN)
A benign, self-limiting respiratory distress syndrome caused by retained fetal lung fluid, most prevalent in infants >37 weeks gestation born via cesarean delivery or rapid delivery lacking the thoracic 'squeeze'; characterized by increased work of breathing without high oxygen requirements that begins at delivery and resolves within approximately 72 hours.
Meconium Aspiration Syndrome (MAS)
Severe respiratory distress occurring predominantly in term or post-term infants who inhale meconium-stained amniotic fluid in utero or during delivery; causes profound chemical pneumonitis, airway inflammation, and secondary Persistent Pulmonary Hypertension (PPHN), with clinical symptoms appearing 24–48 hours postpartum.
Persistent Pulmonary Hypertension of the Newborn (PPHN)
A condition characterized by elevated pulmonary vascular resistance exceeding systemic blood pressure, causing deoxygenated blood to bypass the lungs through right-to-left shunts; results in refractory hypoxemia unresponsive to 100% supplemental oxygen, most commonly appearing 24–48 hours after delivery.

Tension Pneumothorax
A medical emergency in which air progressively accumulates in the pleural space between the chest wall and the lung, causing complete collapse of the lung and shifting the mediastinum to compress the heart, great vessels, and contralateral lung; requires urgent needle thoracostomy decompression.
Early Onset Sepsis
A congenital or perinatally acquired bacterial bloodstream infection linked to pregnancy, labor, or delivery complications, presenting within the first 3–4 days of life and most commonly caused by Escherichia coli or Group B Streptococcus (GBS).
Late Onset Sepsis
A nosocomial (hospital-acquired) bacterial bloodstream infection manifesting after 4–5 days of life, typically transmitted via invasive vascular lines, endotracheal tubes, or invasive procedures, with common pathogens including Escherichia coli, Klebsiella, and Pseudomonas.
WBC Left Shift
A hematologic finding on a complete blood count (CBC) with differential indicating an active bacterial infection, characterized by a diminished proportion of mature white blood cells and an increased proportion of immature precursor cells.
Thrombocytopenia
A diagnostic marker observed in neonatal sepsis characterized by a pathologically low platelet count secondary to bone marrow platelet suppression.

Congenital Toxoplasmosis
A congenital parasitic infection transmitted to the fetus from maternal ingestion of contaminated meat or contact with cat feces; clinically causes hydrocephalus, intracerebral lesions, hepatosplenomegaly, jaundice, and chorioretinitis.

Congenital Rubella
A congenital viral infection characterized by a clinical triad of ocular cataracts, patent ductus arteriosus (PDA), and microcephaly.

Cytomegalovirus (cCMV)
The most common congenital viral infection, characterized by sensorineural hearing loss, chorioretinitis, microcephaly, lower limb spasticity, hepatosplenomegaly, jaundice, thrombocytopenia, and a petechial 'blueberry muffin' rash.

Congenital Herpes Virus
A perinatal viral infection whose classic presentation is a localized cluster of fluid-filled vesicular pustules; due to neonatal immune immaturity, it can rapidly disseminate to cause extensive central nervous system or multiorgan failure and death.

Oral Candida (Thrush)
A fungal infection presenting as confluent, adherent white plaques on the tongue and buccal mucosa that cannot be scraped away with a tongue depressor; impairs infant feeding and requires simultaneous treatment of infant and mother with oral nystatin.

Diaper Candida
An erythematous fungal rash involving the perineum and skin folds, distinguished by sharp borders and inflamed satellite pustules or papules; treated by keeping the diaper area dry and applying topical nystatin cream or powder.
Retinopathy of Prematurity (ROP)
An ocular vasoproliferative disorder affecting premature and small for gestational age neonates exposed to hyperoxia and oxidative stress; characterized by abnormal vascular proliferation and scarring in the retina that can cause retinal detachment and permanent blindness.
Fungal Sepsis
A systemic mycotic bloodstream infection occurring primarily in preterm infants with prolonged exposure to broad-spectrum antibiotics, managed with intravenous antifungal medications.
Acceptable Neonatal Weight Loss
A physiological post-delivery weight decline of up to 10% of birth weight in full-term neonates and up to 15% of birth weight in preterm neonates.
Neonatal Weight Gain Goal
The standard NICU nutritional growth target of 20g/kg/d of weight gain (equivalent to 40g/day in a 2kg infant).
Caloric Density of Term Formula and Breast Milk
Unfortified maternal breast milk and term infant formulas provide 20cal/oz, which may be fortified up to 30cal/oz using human milk fortifiers to support premature or hypermetabolic growth demands.
Hypoxic Ischemic Encephalopathy (HIE)
A neonatal brain injury resulting from an acute intrapartum or perinatal asphyxial event (e.g., placental abruption, umbilical cord prolapse, shoulder dystocia, or maternal collapse) that predisposes the infant to seizures, cerebral palsy, cognitive deficits, and developmental delay.
Therapeutic Hypothermia Protocol
A neuroprotective hypothermia regimen that cools the neonatal body to a target core temperature of 33.5∘C (92.3∘F) for 72 hours to diminish the secondary metabolic cascade, reduce cerebral edema, and improve neurodevelopmental outcomes.
Therapeutic Hypothermia Qualifications
Inclusion criteria for neonatal cooling: gestational age >36 weeks, birth weight >1800g (4lbs), age <6 hours at the time of initiation, documented acute perinatal hypoxic insult, compromised cord or neonatal blood gases, low APGAR scores, extensive resuscitation, and an abnormal neurological examination.
Neonatal Opioid Withdrawal Signs
A constellation of neurobehavioral and autonomic symptoms following in utero opiate exposure, including jitteriness, uncoordinated suck-swallow, inconsolable crying, sleep deprivation, skin excoriation from hyperkinesis, vomiting, diarrhea, frequent sneezing, hyperthermia, hypertonia, high-pitched crying, and seizures.
Finnegan and Eat, Sleep, Console (ESC)
Validated clinical assessment scoring tools utilized in the NICU to quantify the severity of neonatal opioid withdrawal syndrome and guide non-pharmacological and pharmacological interventions.
Neonatal Cocaine Exposure
In utero maternal stimulant exposure associated with severe fetal hypoxia, intrauterine growth restriction (IUGR), placental abruption, stillbirth, and postpartum manifestations of hypertonia, tremors, high-pitched crying, and poor feeding.
Fetal Alcohol Syndrome (FAS)
A congenital syndrome caused by maternal alcohol teratogenesis, characterized by intrauterine growth restriction, cognitive disabilities, and distinctive craniofacial abnormalities: microcephaly, small eye openings (short palpebral fissures), a smooth/thin philtrum, and micrognathia (small jaw).
Neonatal Tobacco Exposure
Prenatal nicotine exposure that leads to neonatal withdrawal symptoms (irritability, jitteriness, hypertonia, poor feeding) and significantly elevates the long-term risk of preterm delivery, placental abruption, sudden infant death syndrome (SIDS), lifelong asthma/respiratory issues, and childhood obesity.
Neonatal SSRI Exposure
In utero maternal selective serotonin reuptake inhibitor exposure that can produce neonatal withdrawal-like symptoms (hypertonia, jitteriness, irritability, seizures) and confers an increased risk of autism and neurobehavioral disorders.
Bilirubin Elimination
The physiological clearance of unconjugated bilirubin, produced by normal neonatal erythrocyte breakdown, which is conjugated by hepatocytes and excreted from the body via stool and urine; dependent on establishing adequate enteral feeding and elimination.
Kernicterus (Acute Bilirubin Encephalopathy)
A severe, irreversible neurological syndrome resulting from the deposition of unconjugated bilirubin across the blood-brain barrier into basal ganglia and brainstem nuclei, causing cerebral necrosis, choreoathetoid cerebral palsy, sensorineural deafness, hypotonia, and intellectual disabilities.
Physiologic Jaundice
A common, benign neonatal hyperbilirubinemia that becomes clinically visible after 24 hours of life, progresses in a cephalocaudal direction, and peaks around day of life 3 in full-term infants and days of life 5–6 in preterm infants.
Phototherapy
A therapeutic modality utilizing blue-green spectrum light to photo-isomerize unconjugated bilirubin deposited in subcutaneous capillary beds into water-soluble structural isomers (lumirubin) that are excreted directly via urine and bile without hepatic conjugation.
Exchange Transfusion
An emergency therapeutic procedure for critical hyperbilirubinemia or hemolytic disease in which 80–85% of the infant's total blood volume is sequentially removed and replaced with cross-matched donor blood containing low bilirubin levels.

Spina Bifida Spectrum
Congenital neural tube defects that include spina bifida occulta (vertebral arch non-fusion without herniation), meningocele (cystic external protrusion containing meninges and cerebrospinal fluid), and myelomeningocele (severe herniation containing both meninges and the spinal cord/neural roots).
Extremely Preterm
A prematurity classification defined as an infant born at a gestational age of strictly less than 28 weeks (<28 weeks).
Very Preterm
A prematurity classification defined as an infant born from 28 weeks through 31 weeks and 6 days (28w to 31w6d) of gestation.
Late Preterm
A prematurity classification defined as an infant born from 34 weeks through 36 weeks and 6 days (34w to 36w6d) of gestation.
Preterm Thermoregulation Bundle (<32 Weeks)
A bundle of evidence-based practices initiated immediately upon delivery for infants <32 weeks to prevent hypothermia: applying a thermal hat, utilizing a thermal mattress, elevating the ambient room temperature to >78∘F, placing the baby inside an occlusive plastic wrap without drying, and admitting to a preheated, humidified (80–90%) isolette.
Respiratory Distress Syndrome (RDS)
A neonatal lung disease caused by developmental surfactant deficiency and alveolar collapse, occurring immediately after birth with an incidence inversely proportional to gestational age; treated with exogenous surfactant replacement via an endotracheal tube.
Apnea of Prematurity
A developmental disorder stemming from an immature brainstem respiratory control center, defined as spontaneous cessations of breathing lasting longer than 20 seconds; most prevalent in neonates born <30 weeks gestation and treated with non-invasive ventilation and intravenous caffeine citrate.
Bronchopulmonary Dysplasia (BPD) / Chronic Lung Disease (CLD)
An acquired iatrogenic chronic lung disease of prematurity characterized by cystic fibrous scarring and arrested alveolar septation on chest X-ray; caused by prolonged positive pressure barotrauma and oxygen toxicity, frequently resulting in prolonged oxygen or mechanical ventilator dependence.

Patent Ductus Arteriosus (PDA)
A persistent congenital connection between the descending aorta and the pulmonary artery that fails to close physiologically after birth in premature infants, resulting in a systolic murmur and pulmonary hyperperfusion.

Germinal Matrix
A fragile, richly vascularized subependymal cellular structure adjacent to the lateral ventricles that is uniquely prone to hypoxic-ischemic rupture and Intraventricular Hemorrhage (IVH) in premature neonates <30 weeks gestation.
Necrotizing Enterocolitis (NEC)
A fulminant ischemic and inflammatory bowel necrosis occurring primarily in premature neonates following the initiation of enteral feeds, most commonly localized to the terminal ileum or proximal colon and carrying a mortality rate of 20–30%.